Back to Nephrology

OUR EXPERTISE AND SERVICES AVAILABLE IN

Kidney Disease

Overview

Spherix’s coverage of the chronic kidney disease market monitors the dynamic and evolving landscape of CKD non-dialysis patient management. We closely track the competitive hyperkalemia market, along with the rapidly evolving diabetic kidney disease market, with specific deep-dives into SGLT2 inhibitors and their potential seismic market impacts. This research also delves into other disease states impacting CKD non-dialysis patients, such as metabolic acidosis and hypertension.

Services Available

Trending market evolution

  • Chronic Kidney Disease (US) – Diabetic Kidney Disease, Hyperkalemia, Hypertension, and Metabolic Acidosis - quarterly, n=100

Exploring the patient journey

  • Chronic Kidney Disease, Non-Dialysis (US) - n=1,000 patient charts

  • Chronic Kidney Disease, Non-Dialysis – PCP Perspective (US) - n=1,000 patient charts

  • Dialysis (US) - n=1,000 patient charts

  • Incident Dialysis (US) - n=650 patient charts

Prepping for the pipeline

  • Metabolic Acidosis (US)

  • Uremic Pruritus (US)

Gauging impact of disruptive events

  • Multi-Specialty Impact of COVID-19 (US)

Learn more about our services

  • HOW CAN WE PARTNER TOGETHER?

    Get more information on Kidney Disease Coverage